Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.

Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty Cannabis.

Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘05.09.24.S1’. The present disclosure relates to seeds of the hemp plant ‘05.09.24.S1,’ to plants and parts of the hemp plant ‘05.09.24.S1,’ and to methods for producing a hemp plant by crossing the hemp plant ‘05.09.24.S1’ with itself or other cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.

Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘095101’. The present disclosure relates to seeds of the hemp plant ‘095101,’ to plants and parts of the hemp plant ‘095101,’ and to methods for producing a hemp plant by crossing the hemp plant ‘095101’ with itself or other cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.

Abstract: The disclosure relates to systems, apparatuses, and methods for estimating a terpene level of two or more terpenes of the plurality of terpenes in the sample to generate a set of terpene levels; and/or estimating a cannabinoid level of two or more cannabinoids of the plurality of cannabinoids in the sample to generate a set of cannabinoid levels; configured to store a set of groups and classify the sample to a group of the set of groups, based on said terpene and cannabinoid levels. The present disclosure also relates to systems, apparatuses, and methods configured to generate entourage effect values and organoleptic values, based on said cannabinoid and terpene levels.

Abstract: The present invention provides new and distinct Cannabis cultivars designated as ‘HAPPY PINEAPPLE’. Disclosed herein are main terpenes of ‘HAPPY PINEAPPLE’, which are beta-ocimene, beta-caryophyllene, alpha-pinene, limonene, alpha-humulene, beta-pinene and myrcene. Also, the present invention provides the estimated concentration of the THCmax about 14.50-18.57% and CBDmax about 0.00%, respectively, at the time of assaying metabolites from flower samples of ‘HAPPY PINEAPPLE’.

Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.

Abstract: The present invention teaches methods useful for accurately and precisely analyzing cannabis plants, plant parts, and extract samples. In particular, the present invention teaches methods of extracting, and quantifying cannabinoid and terpene constituents.

Abstract: Apparatuses, methods, and compositions for administering vaporized caryophyllene compositions to a human subject in need thereof. The caryophyllene compositions can be administered via a handheld electronic device that vaporizes pure, essentially pure, or substantially pure caryophyllene (beta caryophyllene and/or alpha caryophyllene) in small doses for inhalation by a user. Some compositions do not include or contain additional constituents, carriers, or additives, and demonstrate beneficial physiological effects that are not seen when alpha caryophyllene or beta caryophyllene is administered orally or by injection.

Abstract: The invention provides compositions and methods for the breeding, production, processing and use of medical cannabis.

Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘OG CITRON’.

Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘RASPBERRY PUNCH’.

Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘GRAPE LOLIPOP’. Disclosed herein are main terpenes of ‘GRAPE LOLIPOP’, which are myrcene, limonene, beta-caryophyllene, alpha-pinene, alpha-humulene, beta-pinene, and linalool. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 3.09-7.59%, about 9.97-16.68% and about 0.21-0.70% respectively, at the time of assaying metabolites from flower samples of ‘GRAPE LOLIPOP’.

Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘PRIMO CHERRY’. Disclosed herein are main terpenes of ‘PRIMO CHERRY’, which are myrcene, alpha-pinene, hexyl butyrate, beta-pinene, limonene, and linalool. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 12.38-15.24%, about 5.40-7.13%, and about 0.22-0.33%, respectively, at the time of assaying metabolites from flower samples of ‘PRIMO CHERRY’.

Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘HOLY CRUNCH’. Disclosed herein are main terpenes of ‘HOLY CRUNCH’, which are beta-caryophyllene, limonene, myrcene, linalool, alpha-humulene, trans-ocimene, alpha-bisabolol, and alpha-pinene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 6.56-16.74%, about 6.49-15.28%, and about 0.25-1.87%, respectively, at the time of assaying metabolites from flower samples of ‘HOLY CRUNCH’.

Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘RASPBERRY PUNCH’. Disclosed herein are main terpenes of ‘RASPBERRY PUNCH,’ which are limonene, myrcene, beta-caryophyllene, linalool, alpha-humulene, alpha-bisabolol, and beta-pinene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 4.94-8.64%, about 12.04-17.74%, and about 0.59-1.01%, respectively, at the time of assaying metabolites from flower samples of ‘RASPBERRY PUNCH’.

Abstract: The present invention provides a new and distinct Cannabis cultivar designated as ‘RAINBOW GUMMEEZ.’ Disclosed herein are main terpenes of ‘RAINBOW GUMMEEZ’ which are terpinolene, myreene, alpha-pinene, alpha-terpineol, trans-ocimene, beta-pinene, and beta caryophyllene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax and CBGmax, about 4.37-7.87%, about 5.18-9.48%, and about 0.14-0.60%, respectively, at the time of assaying metabolites from flower samples of ‘RAINBOW GUMMEEZ.

Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘BIHEMP 050924.’ Disclosed herein are main terpenes of ‘BIHEMP 050924,’ which are beta-caryophyllene, limonene, alpha-humulene, linalool, myrcene, trans-ocimene, beta-pinene, fenchol, and alpha-terpineol. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 0.21-0.43%, about 5.02-10.86%, and about 0.10-0.72%, respectively, at the time of assaying metabolites from flower samples of ‘BIHEMP 050924.

Abstract: Disclosed herein are main terpenes of ‘OG CITRON’, which are linalool, limonene, myrcene, beta-caryophyllene, alpha-bisabolol, alpha-humulene, and beta-pinene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 9.90-12.66%, about 5.50-9.23%, and about 0.08-0.78%, respectively, at the time of assaying metabolites from flower samples of ‘OG CITRON’.

Abstract: The present invention provides new and distinct Cannabis cultivars designated as ‘HAPPY PINEAPPLE’. Disclosed herein are main terpenes of ‘HAPPY PINEAPPLE’, which are beta-ocimene, beta-caryophyllene, alpha-pinene, limonene, alpha-humulene, beta-pinene and myrcene. Also, the present invention provides the estimated concentration of the THCmax about 14.50-18.57% and CBDmax about 0.00%, respectively, at the time of assaying metabolites from flower samples of ‘HAPPY PINEAPPLE’.